Related Experiment Video
Updated: Aug 23, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
[No improvement of lipodystrophy syndrome in an HIV-infected patient]
Massimiliano Lanzafame1, Federica Faggian, Emanuela Lattuada
1Divisione Clinicizzata di Malattie Infettive, Ospedale Civile Maggiore Borgo Trento, Verona. masino69@hotmail.com
Abstract:
Lipodystrophy in patients with HIV-infection has been studied intensively to understand its epidemiology and pathophysiology. Recently its development was attributed to a dysregulation of TNF-alpha synthesis' homeostasis by HAART. A few years ago it was found that pentoxifylline decreases TNF-alpha production. We describe one HIV-infected patient, with lipodystrophy syndrome, treated with pentoxifylline without any improvement of lipodystrophic symptoms.
